Titel

Merkliste
1 Ergebnisse

Advanced non-small-cell lung cancer: how to manage EGFR and..:

Giulio Metro ; Andrea De Giglio ; Biagio Ricciuti...
https://www.drugsincontext.com/advanced-non-small-cell-lung-cancer-how-to-manage-egfr-and-her2-exon-20-insertion-mutation-positive-disease. , 2022

Link: https://doi.org/10.7573/dic.2022-3-9

RT Journal
T1 <Title>Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7f25efcbc0634ca08522dde133c6dc91&Exemplar=1&LAN=DE
				
A1 Giulio Metro
A1 Andrea De Giglio
A1 Biagio Ricciuti
A1 Marco Siringo
A1 Daniele Marinelli
A1 Alain Gelibter
A1 Federica Pecci
A1 Rossana Berardi
A1 Luca Cantini
A1 Alessandro Di Federico
A1 Elisa Andrini
A1 Mirta Mosca
A1 Giuseppe Lamberti
A1 Marta Brambilla
A1 Giannis Mountzios
PB BioExcel Publishing Ltd
YR 2022
K1 amivantamab
K1 egfr exon 20 insertion mutations
K1 her2 mutation
K1 mobocertinib
K1 non-small-cell lung cancer
K1 poziotinib
K1 trastuzumab deruxtecan
K1 Therapeutics. Pharmacology
K1 RM1-950
JF https://www.drugsincontext.com/advanced-non-small-cell-lung-cancer-how-to-manage-egfr-and-her2-exon-20-insertion-mutation-positive-disease
LK http://dx.doi.org/https://doi.org/10.7573/dic.2022-3-9
DO https://doi.org/10.7573/dic.2022-3-9
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)